K192239: WavelinQ Plus EndoAVF System (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K192239 (WavelinQ Plus EndoAVF System, cleared 2019-10-17 for C.R. Bard, Inc.) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K192239 |
| Cleared Device Trade / Generic Name | WavelinQ Plus EndoAVF System |
| FDA Applicant on Filing | C.R. Bard, Inc. |
| FDA 3-Letter Product Classification | Product Code PQK |
| FDA Substantial Equivalence Decision Date | 2019-10-17 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Becton, Dickinson and Company (BD) across sibling Meru public-data platforms.
Inspect consolidated manufacturer lineage at C.R. Bard, Inc., compare peer devices under FDA Product Code PQK, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.